newsfilter
← Latest News
PR Newswire·

Novavax to Participate in Jefferies London Healthcare Conference

  • Novavax Inc. (Nasdaq: NVAX) announced management will attend the Jefferies London Healthcare Conference in London, UK.
  • A fireside chat is scheduled for Tuesday, November 17, 2026, at 5:00 p.m. GMT.
  • The event will be live-streamed on the Company's "Events & Presentations" page at ir.novavax.com.
  • A replay of the webcast will be accessible for 30 days after the presentation.
  • Novavax leverages its Matrix-M adjuvant & protein-based nanoparticle technology to address global health challenges.
  • The Company's growth strategy focuses on three pillars: technology partnerships, capital-efficient R&D innovation, & a lean operating model.
  • Strategic efforts aim to maximize impact for marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology, & R&D assets.
  • Investor inquiries can be directed to Naina Zaman at 240-410-5353 or [email protected].
  • Media inquiries should be directed to Yvonne Sprow at 240-720-7804 or [email protected].
Company
Novavax, Inc.
Keywords
Novavax, Inc.